Compare SSTI & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SSTI | CPIX |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.4M | 73.6M |
| IPO Year | 2017 | 2007 |
| Metric | SSTI | CPIX |
|---|---|---|
| Price | $7.03 | $4.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 69.2K | ★ 1.8M |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | N/A | ★ N/A |
| Revenue | $34,753,000.00 | ★ $42,010,949.00 |
| Revenue This Year | $7.43 | N/A |
| Revenue Next Year | $6.25 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 46.25 | 16.75 |
| 52 Week Low | $5.78 | $1.85 |
| 52 Week High | $16.92 | $6.27 |
| Indicator | SSTI | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 56.78 | 75.49 |
| Support Level | $6.33 | $2.89 |
| Resistance Level | $7.19 | $5.21 |
| Average True Range (ATR) | 0.25 | 0.40 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 74.07 | 51.31 |
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes: ShotSpotter, the acoustic gunshot detection system; CrimeTracer, the foremost law enforcement search engine; CaseBuilder, a one-stop investigation management system; ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact; PlateRangerTM powered by Rekor, an automatic license plate recognition ("ALPR") and vehicle identification solution; SafePointe, an AI-based weapons detection system.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.